Comparison of fungal and nonfungal infections in a broad-based surgical patient population

Surgical Infections

Volumn 6, Issue 1, 2005, Pages 55-64

  Hughes, Michael G ^a   Chong, Tae W ^a   Smith, Robert L ^a   Evans, Heather L ^a   Pruett, Timothy L ^a   Sawyer, Robert G ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN; ANTIVIRUS AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; FLUCONAZOLE; ITRACONAZOLE; MACROLIDE; METRONIDAZOLE; MONOBACTAM DERIVATIVE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; VANCOMYCIN;

ARTICLE; ARTIFICIAL VENTILATION; ASPERGILLUS; BLOOD TRANSFUSION; CANDIDA ALBICANS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FUNGUS ISOLATION; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; MYCOSIS; NONHUMAN; PREDICTION; PRIORITY JOURNAL; SURGICAL INFECTION; SURGICAL PATIENT; UNITED STATES; UNIVERSITY HOSPITAL; WARD;

ANTI-BACTERIAL AGENTS; APACHE; ASPERGILLUS; BACTERIAL INFECTIONS; CANDIDA ALBICANS; COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; MYCOSES; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURGICAL WOUND INFECTION; TIME FACTORS;

EID: 19044378608     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2005.6.55     Document Type: Article

References (17)

1. Pelz RK, Hendrix CW, Swoboda SM, et al. Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg 2001;233:542-548.
2. Eggimann P, Francioli P, Bille J, et al. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 1999;27: 1066-1072.
3. Sasse KC, Nauenberg E, Long A, et al. Long-term survival after intensive care unit admission with sepsis. Crit Care Med 1995;23:1040-1047.
4. Pittet D, Li N, Woolson RF, Wenzel RP. Microbiological factors influencing the outcome of nosocomial bloodstream infections: A 6-year validated, population-based model. Clin Infect Dis 1997;24:1068-1078.
5. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med 2002;113:480-485.
6. Bartizal K, Gill CJ, Abruzzo GK, et al. In vitro pre-clinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872). Antimicrob Agents Chemother 1997;41:2326-2332.
7. Hughes MG, Evans HL, Lightfoot L, et al. Does prior transfusion worsen outcomes from infection in surgical patients? Surg Infect 2003;4:335-343.
8. Abbott KC, Hypolite I, Tveit DJ. Hospitalizations for fungal infections after initiation of chronic dialysis in the United States. Nephron 2001;89:426-432.
9. Harris AD, Castro J, Sheppard DC, et al. Risk factors for nosocomial candiduria due to Candida glabrata and Candida albicans. Clin Infect Dis 1999;29:926-928.
10. Dupont H, Bourichon A, Paugam-Burtz C, et al. Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis? Crit Care Med 2003;31:752-757.
11. Lupetti A, Tavanti A, Davini P, et al. Horizontal transmission of Candida parapsilosis candidemia in a neonatal intensive care unit. J Clin Microbiol 2002;40:2363-2369.
12. Pittet D, Monod M, Suter PM, et al. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994;220:751-758.
13. Lortholary O, Improvisi L, Fitting C, et al. Influence of gender and age on course of infection and cytokine responses in mice with disseminated Cryptococcus neoformans infection. Clin Microbiol Infect 2002;8:31-37.
14. Goldie SJ, Kiernan-Tridle L, Torres C, et al. Fungal peritonitis in a large chronic peritoneal dialysis population: A report of 55 episodes. Am J Kidney Dis 1996;28:86-91.
15. Wey SB, Mori M, Pfaller MA, et al. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med 1989;149:2349-2353.
16. Fraser VJ, Jones M, Dunkel J, et al. Candidemia in a tertiary care hospital: Epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992;15:414-421.
17. Rex JH, Pappas PG, Karchmer AW, et al. A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects. Clin Infect Dis 2003;36:1221-1228.